Skip to main content
Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
1.960
0.00 (0.00%)
At close: Dec 11, 2024, 4:00 PM
1.950
-0.010 (-0.51%)
Pre-market: Dec 12, 2024, 8:50 AM EST

Longeveron Revenue

Longeveron had revenue of $773.00K in the quarter ending September 30, 2024, with 415.33% growth. This brings the company's revenue in the last twelve months to $1.85M, up 141.46% year-over-year. In the year 2023, Longeveron had annual revenue of $709.00K, down -41.98%.

Revenue (ttm)
$1.85M
Revenue Growth
+141.46%
P/S Ratio
6.64
Revenue / Employee
$77,167
Employees
24
Market Cap
29.08M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023709.00K-513.00K-41.98%
Dec 31, 20221.22M-84.00K-6.43%
Dec 31, 20211.31M-4.32M-76.80%
Dec 31, 20205.63M-10.47K-0.19%
Dec 31, 20195.64M3.50M164.17%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
HOOKIPA Pharma 50.00M
IRIDEX 48.43M
Carisma Therapeutics 20.27M
Surrozen 10.00M
Moolec Science 5.63M
Daré Bioscience 1.88M
IGC Pharma 1.18M
Pluri 598.00K
Revenue Rankings

LGVN News

More News